Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
How CDM Is Evolving to Counter Emerging Cyber Threats
CISA’s Acting Associate Director for Capacity Building and CDM Program Director discusses how the program is now tackling threat mitigation.
31m watch -
Edge AI Brings Faster Decision-Making to Federal Missions
Edge AI can help process data faster in dispersed environments such as battlefield medicine, satellites and wildfires.
4m read -
Who’s in Charge of AI and SI at Top Federal Agencies
New AI memos from the Trump administration prompt federal agencies to establish chief AI officers and OMB to launch a new CAIO AI Council.
7m read -
Federal CISO's Four Priorities to Strengthen Cybersecurity
Federal CISOs are shifting toward proactive risk management as rapidly advancing AI capabilities increase pressure on agencies to modernize.
3m read
